Beijing Science Sun Pharmaceutical Co Ltd (300485) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.68 Million ≈ $4.20 Million USD) by net assets (CN¥3.43 Billion ≈ $502.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300485 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Beijing Science Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Science Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fujian Rongji Software Co Ltd SHE:002474	-0.005x
China Master Logistics Co Ltd SHG:603967	0.060x
SeaBird Exploration Plc OL:SBX	0.148x
Zhejiang Feida Environmental Science & Technology Co Ltd SHG:600526	0.064x
Sichuan Zhongguang Lightning Protection Technologies Co Ltd SHE:300414	0.005x
Heren Health Co Ltd SHE:300550	0.006x
Invesco Mortgage Capital Inc NYSE:IVR	0.047x
DXN HOLDINGS BHD. KLSE:5318	0.041x

Annual Cash Flow Conversion Efficiency for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Beijing Science Sun Pharmaceutical Co Lt.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.39 Billion ≈ $495.39 Million	CN¥135.97 Million ≈ $19.90 Million	0.040x	+556.62%
2023-12-31	CN¥3.47 Billion ≈ $507.42 Million	CN¥21.21 Million ≈ $3.10 Million	0.006x	-81.10%
2022-12-31	CN¥3.41 Billion ≈ $499.28 Million	CN¥110.43 Million ≈ $16.16 Million	0.032x	-42.03%
2021-12-31	CN¥3.28 Billion ≈ $480.42 Million	CN¥183.30 Million ≈ $26.82 Million	0.056x	-39.67%
2020-12-31	CN¥2.85 Billion ≈ $417.03 Million	CN¥263.73 Million ≈ $38.59 Million	0.093x	+45.43%
2019-12-31	CN¥2.71 Billion ≈ $396.74 Million	CN¥172.52 Million ≈ $25.25 Million	0.064x	+10.99%
2018-12-31	CN¥2.56 Billion ≈ $373.95 Million	CN¥146.52 Million ≈ $21.44 Million	0.057x	+22.89%
2017-12-31	CN¥2.32 Billion ≈ $339.41 Million	CN¥108.21 Million ≈ $15.83 Million	0.047x	-54.03%
2016-12-31	CN¥2.10 Billion ≈ $307.00 Million	CN¥212.89 Million ≈ $31.15 Million	0.101x	+12.82%
2015-12-31	CN¥1.88 Billion ≈ $275.51 Million	CN¥169.36 Million ≈ $24.78 Million	0.090x	-72.85%
2014-12-31	CN¥646.64 Million ≈ $94.62 Million	CN¥214.23 Million ≈ $31.35 Million	0.331x	-16.90%
2013-12-31	CN¥493.71 Million ≈ $72.25 Million	CN¥196.82 Million ≈ $28.80 Million	0.399x	-5.55%
2012-12-31	CN¥359.96 Million ≈ $52.67 Million	CN¥151.93 Million ≈ $22.23 Million	0.422x	+35.50%
2011-12-31	CN¥247.37 Million ≈ $36.20 Million	CN¥77.06 Million ≈ $11.28 Million	0.312x	--

About Beijing Science Sun Pharmaceutical Co Ltd

SHE:300485 China Drug Manufacturers - Specialty & Generic

Market Cap

$574.44 Million

CN¥3.93 Billion CNY

Market Cap Rank

#11673 Global

#3356 in China

Share Price

CN¥8.15

Change (1 day)

+0.00%

52-Week Range

CN¥8.15 - CN¥16.63

All Time High

CN¥40.48